Summary
- Current Price
- As of today, TPST price is $1.30, up +2.36% on
- Current Price All-Time High
- TPST price is currently -100.00% below its historical high of $162,893.25 set on
- Market Cap
- TPST current market cap is $19M, down -20.68% year-over-year
- PE Ratio
- TPST PE ratio is unknown
- Revenue
- TPST current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for TPST is on
Profile
| Metric | Value |
|---|---|
| Full Name | Tempest Therapeutics, Inc. |
| Ticker | NASDAQ: TPST |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | tempesttx.com |
| Employees | 24 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.30 | ||
| Price, 1D Change | +2.36% | |
| $19M | ||
| - | ||
| - | ||
| 1.63 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$6.33 | ||
| EPS, 1Y Change | +67.54% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:13 | |
| Next Split | N/A | N/A |
| Last Ticker Change | MLND | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$6.33 | ||
| EPS Estimate | N/A | -$1.34 |
| EPS Est. Change | N/A | +78.83% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $1.30 | ||
| Price Target | - | $11.00 |
| Price Tgt. Change | - | +746.15% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.32 | -$19.50 | -1,382.56% | |
| -$6.10 | -$6.33 | -3.75% | |
| -$1.34 | N/A | +78.83% | |
| -$1.21 | N/A | +80.88% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -81.15% | ||
| -93.10% | ||
| -20.68% | ||
| -90.33% | ||
| 0.00% | ||
| 0.00% | ||
| +67.54% | ||
| -104.68% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $1.30 | ||
| $4.92 | ||
| $1.80 | ||
| $4.38 | ||
| $1.88 | ||
| -$0.15 | ||
| 1.63 | ||
| $0.14 | ||
| 30.74 | ||
| 75.48% | ||
| 105.92% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$6.33 | ||
| -$266.00K | ||
| - | ||
| -$26.58M | ||
| - | ||
| -$26.26M | ||
| - | ||
| -$26.31M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 1.22 | ||
| 2.50 | ||
| 2.50 | ||
| - | ||
| - | ||
| -20.43 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 23.41 | ||
| -1.21 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $6.67M | ||
| $7.71M | ||
| $19.13M | ||
| $8.27M | ||
| $12.46M | ||
| $3.31M | ||
| $8.14M | ||
| $1.19M | ||
| $1.04M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $26.26M | ||
| $26.31M | ||
| $266.00K | ||
| $0.00 | ||
| $266.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$26.82M | ||
| $0.00 | ||
| $4.26M | ||
| $0.00 | ||
| -$26.82M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Scotiabank | → | |
| HC Wainwright & Co. | → | |
| Scotiabank | → | |
| HC Wainwright & Co. | → | |
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
Screeners with TPST
FAQ
What is the ticker symbol for Tempest Therapeutics, Inc.?
The ticker symbol for Tempest Therapeutics, Inc. is NASDAQ:TPST
Does Tempest Therapeutics, Inc. pay dividends?
No, Tempest Therapeutics, Inc. does not pay dividends
What sector is Tempest Therapeutics, Inc. in?
Tempest Therapeutics, Inc. is in the Healthcare sector
What industry is Tempest Therapeutics, Inc. in?
Tempest Therapeutics, Inc. is in the Biotechnology industry
What country is Tempest Therapeutics, Inc. based in?
Tempest Therapeutics, Inc. is headquartered in United States
When did Tempest Therapeutics, Inc. go public?
Tempest Therapeutics, Inc. initial public offering (IPO) was on November 12, 2012
Is Tempest Therapeutics, Inc. in the S&P 500?
No, Tempest Therapeutics, Inc. is not included in the S&P 500 index
Is Tempest Therapeutics, Inc. in the NASDAQ 100?
No, Tempest Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Tempest Therapeutics, Inc. in the Dow Jones?
No, Tempest Therapeutics, Inc. is not included in the Dow Jones index
When was Tempest Therapeutics, Inc. last earnings report?
Tempest Therapeutics, Inc.'s most recent earnings report was on May 14, 2026
When does Tempest Therapeutics, Inc. report earnings?
The next expected earnings date for Tempest Therapeutics, Inc. is August 11, 2026
Data Sources & References
- TPST Official Website www.tempesttx.com
- TPST Profile on Yahoo Finance finance.yahoo.com/quote/TPST
- TPST Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tpst